METROPOLIS595.00

Metropolis Healthcare Ltd.

· Pharma & Health
AnnualQuarterly₹ CrorePeersLALPATHLABVIJAYATHYROCAREMARKSANSPARKHOSPSJLHLRUBICONHCGMcap ₹12,336 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue from Operations1,207.71,331.21,645.81,710.0
Other Income9.115.125.623.2
Total Income1,216.81,346.31,671.41,733.2
Expenses
+ Cost of Materials Consumed242.6268.7324.5332.6
+ Employee Benefit Expense275.8313.7377.4392.1
+ Finance Costs22.518.624.525.5
+ Depreciation & Amortisation94.5108.7133.7135.3
+ Other Expenses406.8445.8543.1563.1
Total Expenses1,042.11,155.51,403.31,448.5
EBITDA282.6303.0400.8422.3
EBIT188.1194.3267.1287.0
Profit
PBT before Exceptional Items174.7190.9268.2284.6
+ Exceptional Items0.00.0-9.0-9.0
Pretax Income174.7190.9259.2275.7
+ Current Tax49.748.673.777.1
+ Deferred Tax-3.4-3.3-5.7-4.2
Tax Expense46.245.368.072.8
Net Income128.5145.5191.2202.8
+ Net Income — Continuing Ops128.5145.5191.2202.8
+ Other Comprehensive Income-0.8-0.34.89.8
Total Comprehensive Income127.6145.2196.0212.6
Net Income to Common127.8145.0190.0201.6
Minority Interest0.60.51.21.2
Per Share
Basic EPS24.9528.299.1923.35
Diluted EPS24.8728.159.1923.26
Other Comprehensive Income — detail
+ Other Comprehensive Income-0.34.89.8
+ Items NOT to be Reclassified to P&L0.4
+ Tax on Items NOT to be Reclassified1.60.0-0.5
+ Tax on Items NOT to be Reclassified — alt tag1.7
+ Tax on Items to be Reclassified-1.3-4.4-8.8
+ Tax on Items to be Reclassified — alt tag-0.8
Comprehensive Income — Owners of Parent-0.8144.74.8160.5
Comprehensive Income — Non-controlling Interests0.00.50.01.1
Per Share — as-filed variants
Basic EPS — Continuing Operations24.9528.299.1923.35
Diluted EPS — Continuing Operations24.8728.159.1923.26
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit965.11,062.51,321.31,377.4
Gross Margin %79.9179.8280.2880.55
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)174.7190.9268.2284.6
− Exceptional Items (reconciliation)0.00.0-9.0-9.0
Net Income Adj (tax-effected)128.5145.5197.8209.4
EPS Adj24.9528.299.5124.11
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value2.002.002.002.00
Paid Up Equity Capital10.210.441.541.5
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.